key: cord-0849302-rzagwiui authors: Yu, Kaixu; Chen, Ying; Tian, Yahao; Kang, Honglei; Song, Kehan; Dong, Yimin; Peng, Renpeng; Li, Feng title: Characteristics, incidence, and risk factors for death from fatal pneumonia among patients with primary malignant bone tumors: a SEER-based observational study date: 2021-08-03 journal: Transl Cancer Res DOI: 10.21037/tcr-21-306 sha: 75b9655cd717bf76283d52bf77e7d01e05c29e73 doc_id: 849302 cord_uid: rzagwiui BACKGROUND: (I) To determine whether patients with malignant bone tumors had a higher risk of dying from pneumonia compared with the general US population; (II) to identify the independent risk factor associated with fatal pneumonia among these patients. METHODS: We identified 18,583 patients diagnosed with primary malignant bone tumors between 1973 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database. Standardized mortality ratios (SMRs) were calculated based on the mortality data of the general population gathered by the National Center for Health Statistics, which provided the risk of death from pneumonia among cancer patients relative to that of the general population. Given that other causes of death were considered as competing events, we also designed the Fine-Gray model to identify demographic and tumor-related characteristics associated with a higher risk of dying from pneumonia among these patients. RESULTS: Patients with primary malignant bone tumors had a higher risk of dying from pneumonia than the general population after adjusting the distribution difference of age, sex, and race among them (SMR =2.79; 95% CI: 2.17–3.59). The older age, Black and earlier period of diagnosis were found to be the independent prognostic factor for a higher risk of death from pneumonia for these patients. Additionally, amputation due to malignant bone tumors significantly increased the risk of death from pneumonia compared with non-surgery. The highest mortality rate of pneumonia was observed among patients with chordoma. Interaction tests demonstrated that amputation only increased the relative risk of fatal pneumonia among patients with osteosarcoma. Throughout the follow-up period, the mortality rate of fatal pneumonia was the highest within the first year after diagnosis, and the highest relative suicide risks persisted over time in patients with osteosarcoma. CONCLUSIONS: To mitigate the risk of fatal pneumonia among patients with bone tumors, we call for long-term clinical monitoring of the lung condition among these patients, especially for those after amputation for bone tumors. Pneumonia and cancer are the leading causes of death worldwide (1) . In 2017, it was estimated that more than 2 . 5 6 m i l l i o n p e o p l e d i e d f r o m p n e u m o n i a a n d approximately 9.6 million people died from various forms of cancer (1, 2) . Pneumonia caused by influenza was responsible for an estimated 145,000 deaths (3) . With the advances in screening, diagnosis, and treatment of cancer in recent years, the survival rate of cancer patients has significantly improved (4); however, the morbidity and mortality of other non-cancer diseases such as stroke, cardiac disease, and Alzheimer's disease among cancer survivors remain increasing among the cancer survivors (5) (6) (7) (8) . It was reported that pneumonia was a major cause of death among long-term childhood cancer survivors (9) . With age, cancer survivors admitted to the hospital due to pneumonia have an increased risk of dying from pneumonia (9) . Among cancer patients, life-threatening pneumonia was mainly caused by the disease and its treatment comprising poor nutritional status and cytotoxic therapy (10) (11) (12) . Moreover, higher doses of exercise, especially aerobic exercise has proven to be strongly associated with a lower risk of pneumonia mortality in a dose-dependent manner (13, 14) . Among patients with bone tumors, activities are restricted due to pain, distortion of bone and pathological fractures (15) . The change of gait, deviation of appearance, and reductions in function, stability, and strength cause severe impairment of athletic ability of patients with malignant bone tumors, especially in those who underwent amputation (15) (16) (17) . Furthermore, it was recognized that the most of child patients with primary malignant bone tumors usually suffer from malnutrition (18) . These may increase the risk for fatal pneumonia (10, 11, 13, 14) . To the best of our knowledge, there are few guidelines for the primary prevention and management of pneumonia in patients with malignant bone tumors. Therefore, the objectives of this study were to determine the risk of dying from pneumonia among patients with malignant bone tumors relative to that of the general population and to identify demographic and tumor-related characteristics and type of surgery associated with a higher risk of dying from pneumonia. We present the following article in accordance with the STROBE reporting checklist (available at https://dx.doi.org/10.21037/tcr-21-306). Patients diagnosed with malignant bone tumors between January 1st, 1973 and December 31st, 2016 were identified using the Surveillance, Epidemiology, and End Results (SEER) database, a publicly available, nationally representative, population-based cancer database established by the National Cancer Institute (19) . The mortality data of the general US population collected by the National Center for Health Statistics spanning from 1969 to 2017 was also used as a comparison. In this study, all patients with a diagnosis of malignant bone tumors were included. Patients were excluded if their cancer diagnosis were not microscopically confirmed and ages at the times of diagnosis and follow-up time were unknown ( Figure 1 ). In the multivariate analysis, patients who did not have the definitive race, clinical stage, and information for surgery were also excluded. We extracted demographic characteristics from the SEER database, including age at diagnosis (0-14, 15-29, 30-44, 45-59, and 60+ years), sex (female, male), race (white, black, and other), and year of diagnosis (1973-1990, 1991-2000, 2001-2010, and 2011-2016) . The tumor-related variables included the histological subtype, primary site (upper limb, lower limb, skull and face, vertebral column, thorax, pelvis, and others), and clinical stage of the bone tumors [localized (N0M0), regional (N+), distant (M1) and unknown (blank)]. The treatment variables comprised surgery (amputation, limb salvage, surgery, not otherwise specified, and none), chemotherapy (yes and none/unknown), and radiation (yes and none/unknown) for bone tumor. Survival time and cause of death were also available. All patients were divided into five subgroups according to the histological subtype of malignant bone tumors, including osteosarcoma, chondrosarcoma, Ewing sarcoma, chordoma, and others [International Classification of Disease for Oncology third revision codes are listed in (Table 1) ]. Patients with cause of death coded as "pneumonia and influenza (50120)" were considered to have died from pneumonia. The number of deaths from pneumonia divided by personyears of survival was calculated as the mortality rate of pneumonia. Among cancer-patient subgroups stratified by different characteristics, the standardized mortality ratios (SMRs) and 95% confidence intervals (95% CIs) were calculated as described earlier (20) , which provided the relative risk of fatal pneumonia for cancer patients compared with all general US population after adjusting the distribution difference of age, sex, and race among them. Five-year age ranges were used for standardization. In detail, the SMRs were estimated as the ratios of observed to expected number of deaths. The observed number of deaths represents the total number of deaths from fatal pneumonia among patients with bone tumors recorded during the study period; the expected number of deaths represents the number of individuals who died from fatal pneumonia in the general population with the same distribution of age at diagnosis, sex, race (8, 21) . Other causes of non-cancer death other than pneumonia were regarded as competing risk events in the multivariate analysis. Therefore, we designed the Fine-Gray model to identify demographics, tumorrelated characteristics, and type of surgery associated with a higher risk of dying from pneumonia among patients with bone tumors. Interaction tests were further carried out to investigate the potential differential effect of amputation on relative risk of dying from pneumonia among patients with different histological subtype of bone tumors. Survival time recorded as 0 months in the SEER database was converted to one-half of a month according to accepted epidemiologic practices (20) . All statistical tests were 2-sided, and P<0.05 were also considered statistically significant. The analyses were performed using the SEER*Stat software version 8.3.6 and the R version 3.51 statistical software. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Among 18,583 patients suffering from malignant bone tumors followed for 142,082 person-years, a total of 60 deaths due to pneumonia occurred, with a mortality rate of 42.23/100,000 person-years ( Table 1) . Patients with primary malignant bone tumors had a significantly higher risk of dying from pneumonia compared to the general US population with the same distribution of age, sex, and race (SMR =2.79; 95% CI: 2.17-3.59). The interquartile range of survival time was from 1.33 to 11.33 years, with a median survival time of 4.25 years. There were four deaths due to pneumonia observed among patients with malignant bone tumors whose age at diagnosis was less than 19 years ( Figure 2 ). For these young cancer patients, the risk of dying from pneumonia was more than 10-fold greater than that in the general population (SMR =10.07; 95% CI: 5.24-19.36). The relative risk of fatal pneumonia gradually declined as patients with bone tumors grew older. The old patients whose age at diagnosis was more than 80 years old had the highest mortality rate of pneumonia among all age subgroups (1,312.19/100,000 person-years), but the risk of fatal pneumonia of those was equal to that of the general population (SMR =1.80; 95% CI: 0.97-3.34). Blacks had a higher mortality rate of pneumonia despite the least number of deaths (53.43/100,000 person-years; SMR =4.53; 95% CI: 2.16-9.51). Patients who did not undergo surgery had a higher mortality rate of fatal pneumonia compared to patients who underwent surgery. The relative risk of fatal pneumonia was higher among patients who underwent amputation than those who underwent limb salvage or did not undergo surgery. Patients who underwent radiation (65.82/100,000 person-years; SMR =3.53; 95% CI: 2.20-5.68) or did not undergo chemotherapy (60.34/100,000 person-years; SMR =2.57; 95% CI: 1.95-3.39) for malignant bone tumors had a higher risk of fatal pneumonia. The Fine and Gray model indicated that older age at diagnosis and axial tumors were associated with the higher incidence of fatal pneumonia among patients with malignant bone tumors ( Among patients with chordoma, there were eight deaths due to pneumonia, accounting for 13% of all deaths due to pneumonia among patients with malignant bone tumors ( Figure 3 showed the cumulative incidence of death from pneumonia among cancer patients. Among patients with malignant bone tumors, surgical site infection is a common postoperative complication (22, 23) , but few studies have paid attention to pulmonary infection. Using data from the SEER database, we first reported that the risk of dying from pneumonia among patients with primary malignant bone tumors was approximately three- fold that of the general population. The risk factors of dying from pneumonia for these patients included lack of physical activities, prolonged bed rest, and malnutrition (12) (13) (14) 18) . Our study demonstrated that the risk of dying from pneumonia among patients with bone tumors varied greatly by pathological subtypes of malignant bone tumors. In this study, patients with chordoma had the highest risk of dying from pneumonia, which may be associated with the common location of the chordoma. Chordoma is an extremely rare subtype of bone sarcoma and appears anywhere along the central neural axis from the skull base to the sacrum. Patients with chordomas usually present with tingling, numbness, weakness, and radiculopathies related to the level of spinal tumors (24) (25) (26) , which could reduce exercise capacity and prolong the bed-rest time. Radical resection is the most basic treatment for chondroma, and the principles of surgical treatment for chordoma include more aggressive surgery, wider surgical margins, and elaborate reconstructive (27) (28) (29) . Although the benefits of early mobilization after surgery have been well documented, the complexity of a spinal reconstructive procedure and poor overall physiologic condition in the early postoperative period may render early mobilization unfeasible (30) (31) (32) . Additionally, among patients with bone tumors of the vertebral column, higher recurrence rates of spinal bone tumors increase the re-operation rates (33) , thus further increasing the bed-rest time and incidence of in-hospital lung infections (34) (35) (36) . We found that amputation could significantly increase the risk of dying from pneumonia among patients with malignant bone tumors, mainly those associated with a lack of exercise. Patients often experience physical disability and motor dysfunction after amputation (15) . In addition, the change of identity from being a healthy individual to becoming a disabled person has a negative effect on the mental aspects and social life of patients with bone tumors (17, 37) . High levels of anxiety and depression have been observed in patients with bone tumors after remission (38, 39) , which reduce patients' participation in sports and physical activity (15) . To improve the exercise capacity of patients with amputation, clinicians could increase the utilization of sports prosthetic devices or popularize sports programs that do not require prosthetics such as wheelchair exercises or traditional Indian yoga among patients with bone tumors, which were deemed feasible (15, 40) . It was reported that almost one-third of deaths from pneumonia were among children younger than five years (1). Furthermore, although the number of people dying from pneumonia has decreased substantially over the past three decades, the number of deaths among people aged 70 years and older has increased (1). In an investigation of a long-term cancer survivor cohort in England, Smith et al. reported that childhood cancer survivors have a higher additional risk of hospitalization due to pneumonia compared with adolescent and young adult cancer survivors (9) . We found that the young patients had a significantly higher risk of fatal pneumonia than the general population. Even though the patients whose age at diagnosis was more than 85 years had the highest mortality rate from pneumonia, this risk was equal to that of the general population. These meant that for young cancer patients, malignant bone tumors and related treatment play an important role in increased risk of fatal pneumonia, but for old patients, the age was the most predominant factor for the high mortality rate of pneumonia and the effects of tumors were negligible. Therefore, it was necessary to separate young and old patients as two distinct groups when considering the risk of dying from pneumonia among patients with malignant bone tumors. We also found that the risk of dying from pneumonia was the highest within the first year after the initial diagnosis among patients with malignant bone tumors. Furthermore, patients who underwent amputation for bone tumors had a longer high-risk period than patients who did not undergo surgery, in which cancer patients had a higher incidence of fatal pneumonia compared with the general population. A possible hypothesis to explain this was that bone tumors and the related surgery resulted in a higher risk of fatal pneumonia shortly after diagnosis. With the improvement of the nutritional status and the recovery of exercise capacity among patients, the risk of pneumonia decreased gradually. However, the recovery of exercise capacity was difficult and required more time for patients who underwent amputation. These findings highlight that clinicians should have a comprehensive understanding of the factors associated with a higher risk of dying from pneumonia, to mitigate the risk of dying from pneumonia among patients with bone tumors. Our study has several limitations. First, influenza not only causes pneumonia but also has a negative effect on other systems, including the central nervous system and the cardiovascular system (41, 42) . There is a possibility that the patients whose causes of death were coded as "pneumonia and influenza" did not die from pneumonia caused by influenza, but from complications caused by the influenza in the other systems. Second, the higher incidence of fatal pneumonia among patients with amputation is associated with lower dose of exercise, but we could not get quantified data about exercise from SEER database. Therefore, we could not directly evaluate the impact of exercise on the risk of fatal pneumonia among these patients. We first reported that patients with malignant bone tumors had a higher risk of dying from pneumonia compared to the general population. Surgery could decrease the incidence of fatal pneumonia, but amputation could increase the risk. Orthopedic surgeons cannot subjectively change the method of surgery for bone tumors. Therefore, we call for long-term clinical monitoring of the lung condition among these patients. This requires enhanced coordinated multidisciplinary cooperation between orthopedic and respiratory medicine teams. Our World in Data: Cancer Pneumonia GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century Stroke among cancer patients A population-based study of cardiovascular disease mortality risk in US cancer patients Risk of Alzheimer's Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries Incidence of suicide in persons with cancer Respiratory morbidity in young people surviving cancer: Populationbased study of hospital admissions, treatment-related risk factors and subsequent mortality Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management Infectious morbidity in critically ill patients with cancer Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature Dose-response relationship between exercise and respiratory disease mortality Complications of immobilization and bed rest. Part 2: Other complications Amputees and sports: a systematic review Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study Malnutrition in children with cancer: incidence and consequence Surveillance Epidemiology and End Results (SEER) Program: Overview of the SEER Program Epidemiologic Methods: Studying the Occurrence of Illness Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review Risk factors for surgical site infection after malignant bone tumor resection and reconstruction Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients Current management of sacral chordoma Chordoma: current concepts, management, and future directions Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas Prolonged bed rest as adjuvant therapy after complex reconstructive spine surgery The management of burst fractures of the thoracic and lumbar spine. Experience in 53 patients Thoracolumbar burst fractures. The clinical efficacy and outcome of nonoperative management. Spine (Phila Pa Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center Nursing in Pneumonia Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection Delay in operative stabilization of spine fractures in multitrauma patients without neurologic injuries: effects on outcomes What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma Anxiety and Cite this article as Characteristics, incidence, and risk factors for death from fatal pneumonia among patients with primary malignant bone tumors: a SEER-based observational study Persistent psychological distress in long-term survivors of pediatric sarcoma: the experience at a single institution Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review COVID-19 and Cardiovascular Disease Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease We would like to thank EditorBar (https://www.editorbar. com/) for his/her help in polishing our paper. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Institutional ethical approval and informed consent were waived.Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.